Posted on: 23 March, 2022
There are calls for a greater focus on weight management following new research defining the relationship between obesity and pregnancy-related complications for mother and baby.
The study follows an increase in obesity levels globally as well as a rise in prevalence during pregnancy. Today, more than 20 per cent of Australian women have obesity at the time of conception.
Kolling Institute and Univ.....
Read more
Category: Research Excellence
Posted on: 15 March, 2022
Research from the University of Sydney and Royal North Shore Hospital provides insights into cardiac risk among footballers of masters age (35 years and older), an increasingly popular pastime.
In what is believed to be the first study to assess cardiac knowledge and beliefs in this higher-risk amateur football group, researchers have found that one in five players experienced one or more potential.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 14 March, 2022
With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options.
The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 per cent of .....
Read more
Category: Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 04 March, 2022
Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project investigating a revolutionary approach to care for those with neuroendocrine tumours.
Cancer specialists Professor Nick Pavlakis and Dr David Chan will join the AUS-NET trial after a funding announcement by Health Minister Greg Hunt.
The study will assess whether a new patient-specific care model imp.....
Read more
Category: Funding support, Research Excellence
Posted on: 01 March, 2022
A new study by researchers at the Kolling Institute will directly guide the use of medications by older Australians after it identified the profound adverse effects of taking multiple medications.
The study follows the latest figures which show around 50 per cent of Australians over 75 years take five or more medications every day to treat multiple chronic illnesses.
The trend is leading to an incr.....
Read more
Category: Research Excellence
Posted on: 28 February, 2022
The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to examine a revolutionary approach to treatment for those with acute myeloid leukaemia.
This aggressive form of blood cancer has a tragically poor survival rate, and while we have seen tremendous progress for many other types of cancer in recent years, there have been very limited improvements in treat.....
Read more
Category: Funding support, Research Excellence
Posted on: 09 February, 2022
The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities.
The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 contribution, .....
Read more
Category: Research Excellence, World-leading technology
Posted on: 08 February, 2022
Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury.
Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers.
The program was trialled with staff from Aust.....
Read more
Category: Awards, Research Excellence
Posted on: 20 December, 2021
Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk.
Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born early deal with ongoing health problems for the remainder of their lives.
The tea.....
Read more
Category: Research Excellence
Posted on: 20 December, 2021
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19.
Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country.
The study confirmed earlier conce.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence